COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc Has Agreed on a Digitalization and Innovation Loan with Finnvera to Finance Product Development Project
27/06/2024
Company Announcement, Helsinki, 27 June 2024 at 4:45 PM (EEST) Nexstim Plc Has Agreed on a Digitalization and Innovation Loan with Finnvera to Finance Product Development Project Nexstim Plc (NXTMH:HEX) ("Nexstim" or " [...]
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
27/06/2024
Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activities RESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Science [...]
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
27/06/2024
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose [...]
KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
27/06/2024
RIYADH, Saudi Arabia, June 27, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) is at the forefront of the global AI and robotics revolution. These technological advancements [...]
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
27/06/2024
bioLytical Laboratories Inc. helps boost testing efforts across the country with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support testing efforts nationwide Donated rapid tests will be [...]
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASᴳ¹²ᴰ-Selective Dual-State Allosteric Inhibitor, and Other Program Updates
27/06/2024
– Phase 1 clinical trial underway evaluating QTX3046, a novel orally bioavailable and brain-penetrant, non-covalent allosteric G12D-selective-KRAS dual (OFF/ON)-state inhibitor, in patients with KRAS G12D -mutated [...]
GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
27/06/2024
Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI [...]
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
27/06/2024
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024 [...]
AssureCare Expands Collaboration with Large Blues Plan to Implement Its Revolutionary Business Intelligence Platform, Akumen™
27/06/2024
Akumen, a transformational analytics platform, enables health plans to optimize their clinical and administrative operations CINCINNATI, June 27, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of healthcare [...]
NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation
27/06/2024
LANGHORNE, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a Non-covalent Reversible BTK Inhibitor with Once Daily Dosing Potential
27/06/2024
IMG-004 was well tolerated across once daily (QD) doses ranging 50 mg to 300 mg for 10 days. Key liver function parameters remained within the normal reference range for all tested doses. No reports of bleeding events [...]
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
27/06/2024
ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve [...]
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
27/06/2024
CHATHAM, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it has entered into a [...]
Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease
27/06/2024
Data demonstrates improvement in cognitive function in GBA1 Parkinson’s disease model in addition to reversal of motor function deficits BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: [...]
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
27/06/2024
The device is intended for initial treatment in the acute setting SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal [...]
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
27/06/2024
VANCOUVER, Washington, June 27, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam
27/06/2024
Leading women’s reproductive health conference directly follows the company’s EU CE Mark approval for four of its products ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical [...]
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
27/06/2024
Kane Also Signs Long-Term Manufacturing Agreement With Halo Pharma WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made [...]
Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador
27/06/2024
Druski Joins the Company’s Impressive Portfolio of Creators and Celebrities to Boost Awareness of the Revolutionary Beverage with a Wide Range of Consumers JUPITER, FL, June 27, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc [...]

Pages